Calanolide A: Sarawak will begin in 3Q02 a U.S. Phase I trial of Calanolide A in 48 volunteers. Sarawak is a 50-50 joint venture between the state government of

Sarawak MediChem Pharmaceuticals Inc., Lemont, Ill.
Product:

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE